Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
暂无分享,去创建一个
E. Van Cutsem | F. Lordick | C. Punt | M. Ducreux | Y. Hotko | T. Ciuleanu | E. Chan | M. Peeters | T. Price | A. Cervantes | T. André | A. Sobrero | K. Oliner | A. Rong | J. Gansert | V. Tzekova | G. Wilson | A. Strickland | L. Roman | S. Collins | E. Chan